October 5, 2021
Macarius Donneyong, PhD, MPH, assistant professor of outcomes and translational sciences at The Ohio State University College of Pharmacy, has been elected to the American College of Epidemiology (ACE) board of directors.
In this role, Dr. Donneyong will represent ACE members to ensure that their voices and needs are heard. He will play a critical leadership role in advancing the mission and vision of ACE – educating and advocating for epidemiologists in their efforts to promote good science and public health.
“The US is at the crossroads of tackling racial injustices in health and in society and ACE is in a position to lead,” Dr. Donneyong said. “I find it a privilege and an honor to be elected to serve on the board of ACE at this critical time of public health and racial injustice crises.”
ACE is an organization that serves the interests for the epidemiology field and its professionals through advocating for issues important to epidemiology and sponsoring scientific meetings, publications and educational activities while recognizing outstanding contributions in the field.
Dr. Donneyong holds joint faculty appointments in the Colleges of Pharmacy and Public Health at Ohio State. He teaches courses on drug literature evaluation in the PharmD program and a graduate course on health care data analytics at the College of Public Health.
Dr. Donneyong’s research focuses on improving the health of racial/ethnic minorities by generating information to improve adherence, safety and effectiveness of prescribed medication. His major research interests in this area include:
- The direct and indirect role of social determinants of health on medication utilization, adherence and effectiveness;
- The effect of patient-provider relationships on medication treatment outcomes;
- How to prevent harmful effects of drug-drug interactions.
Dr. Donneyong received his Master of Public Health from Missouri State University in 2009 and his PhD from University of Louisville in 2013.